Burden of Itch in Patients with Basal Cell Carcinoma
DOI:
https://doi.org/10.2340/00015555-3871Keywords:
basal cell carcinoma, quality of life, itch, stigmatization, depressionAbstract
The incidence of basal cell carcinoma has increased in recent years. The aim of this study was to analyse the influence of itch on quality of life and psychosocial status of patients with basal cell carcinoma. A total of 180 patients with basal cell carcinoma were included in the study. Itch intensity was assessed with Numerical Rating Scale and 4-Item Itch Questionnaire (4IIQ). Quality of life in basal cell carcinoma was assessed with the 36-item Short-Form Health Survey (SF-36), Dermatology Life Quality Index (DLQI), 6 Item Stigmatization Scale (6-ISS) and Beck Depression Inventory (BDI). Mean DLQI in the study group was 2.0 ± 2.0, while mean SF-36 was 71.38 ± 15.77 points. The intensity of itch assessed with 4IIQ correlated negatively with SF-36 (R = –0.48, p = 0.003). The mean ± SD BDI score was 6.16 ± 5.72 points and mean 6-ISS score was 0.66 ± 1.24. In conclusion, presence and intensity of itch may debilitate quality of life among patients with basal cell carcinoma.
Downloads
References
Poulaliou A, Legoupil D, Schoenlaub P, Herault M, Dupuy-De Fonclare AL, et al. Itch and pain characteristics in skin carcinomas. Acta Derm Venereol 2016; 96: 697–698.
Chlebicka I, Stefaniak AA, Matusiak Ł, Szepietowski JC. Is basal cell carcinoma an itchy tumor? Clinical characteristics of itch in basal cell carcinoma. J Clin Med 2020; 9: 2386.
Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet 2010; 375: 673–685.
Lee HJ, Kim GW, Kim HS, Ko HC, Kim MB, Kim BS. Pruritus in epithelial tumours of the face. J Eur Acad Dermatol Venereol 2017; 31: e496–e497.
Yosipovitch G, Mills KC, Nattkemper LA, Feneran A, Tey HL, Lowenthal BM, et al. Association of pain and itch with depth of invasion and inflammatory cell constitution in skin cancer results of a large clinicopathologic study. JAMA Dermatol 2014; 150: 1160–1166.
Mills KC, Kwatra SG, Feneran AN, Pearce DJ, Williford PM, D’Agostino RB, et al. Itch and pain in nonmelanoma skin cancer: pain as an important feature of cutaneous squamous cell carcinoma. Arch Dermatol 2012; 148: 1422–1423.
Askari SK, Schram SE, Wenner RA, Bowers S, Liu A, Bangerter AK, et al. Evaluation of prospectively collected presenting signs/symptoms of biopsy-proven melanoma, basal cell carcinoma, squamous cell carcinoma, and seborrheic keratosis in an elderly male population. J Am Acad Dermatol 2007; 56: 739–747.
Reich A, Chatzigeorkidis E, Zeidler C, Osada N, Furue M, Takamori K, et al. Tailoring the cut-off values of the visual analogue scale and numeric rating scale in itch assessment. Acta Derm Venereol 2017; 97: 759–760.
Chrostowska-Plak D, Reich A, Szepietowski JC. Relationship between itch and psychological status of patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2013; 27: e239–242.
Wojtowicz-Prus E, Kiliś-Pstrusińska K, Reich A, Zachwieja K, Miklaszewska M, Szczepańska M, et al. Chronic kidney disease-associated pruritus in children. Acta Derm Venereol 2016; 96: 938–942.
Suseł J, Batycka-Baran A, Reich A, Szepietowski JC. Uraemic pruritus markedly affects the quality of life and depressive symptoms in haemodialysis patients with end-stage renal disease. Acta Derm Venereol 2014; 94: 276–281.
Ware JJ. SF-36 Health survey manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–216.
Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659–664.
Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychol. Corp.; 1996.
Furlanetto LM, Mendlowicz MV, Romildo Bueno J. The validity of the Beck Depression Inventory-Short Form as a screening and diagnostic instrument for moderate and severe depression in medical inpatients. J Affect Disord 2005; 86: 87–91.
Lu Y, Duller P, van der Valk PGM, Evers AWM. Helplessness as predictor of perceived stigmatization in patients with psoriasis and atopic dermatitis. Dermatology Psychosom 2003; 4: 146–150.
Gerritsen MJP, De Rie MA, Beljaards RC, Thissen MRTM, Kuipers M V. Survey among patients with basal cell carcinoma in The Netherlands. J Dermatolog Treat 2009; 20: 213–218.
Rhee JS, Matthews BA, Neuburg M, Smith TL, Burzynski M, Nattinger AB. Skin cancer and quality of life: assessment with the Dermatology Life Quality Index. Dermatologic Surg 2004; 30: 525–529.
Holfeld KI, Hogan DJ, Eldemire M, Lane PR. A psychosocial assessment of patients with basal cell carcinoma. J Dermatol Surg Oncol 1990; 16: 750–753.
Blackford S, Roberts D, Salek MS, Finlay A. Basal cell carcinomas cause little handicap. Qual Life Res 1996; 5: 191–194.
Sampogna F, Paradisi A, Iemboli ML, Ricci F, Sonego G, Abeni D. Comparison of quality of life between melanoma and non-melanoma skin cancer patients. Eur J Dermatology 2019; 29: 185–191.
Abedini R, Nasimi M, Noormohammad Pour P, Moghtadaie A, Tohidinik HR. Quality of life in patients with non-melanoma skin cancer: Implications for healthcare education services and supports. J Cancer Educ 2019; 34: 755–759.
Çetinarslan T, Evrenos MK, Bilaç C, Özyurt B, Türel Ermertcan. A Evaluation of the effect of surgical treatment on quality of life with the Dermatology Life Quality Index in patients with facial nonmelanoma skin cancer. Dermatol Ther 2020; 33: e14094.
Steinbauer J, Koller M, Kohl E, Karrer S, Landthaler M, Szeimies RM. Lebensqualität in der Versorgung des nichtmelanozytären Hautkrebses? Ergebnisse einer Pilotstudie. J Ger Soc Dermatol 2011; 9: 129–135.
Villani A, Fabbrocini G, Cappello M, Costa C, Scalvenzi M. Real-life effectiveness of vismodegib in patients with metastatic and advanced basal cell carcinoma: Characterization of adverse events and assessment of health-related quality of life using the Dermatology Life Quality Index (DLQI) test. Dermatol Ther 2019; 9: 505–510.
Matusiak Ł, Szczęch J, Kaaz K, Lelonek E, Szepietowski JC. Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa. Acta Derm Venereol 2018; 98: 191–194.
Mann C, Dreher M, Weess HG, Staubach P. Sleep disturbance in patients with urticaria and atopic dermatitis: an underestimated burden. Acta Derm Venereol 2020; 100: adv00073.
Williamson D, Gonzalez M, Finlay AY. The effect of hair loss in quality of life. J Eur Acad Dermatol Venereol 2001; 15: 137–139.
Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140: 672–676.
Nichol MB, Margolies JE, Lippa E, Rowe M, Quell J. The application of multiple quality-of-life instruments in individuals with mild-to-moderate psoriasis. Pharmacoeconomics 1996; 10: 644–653.
Harris A, Burge SM, Dykes PJ, Finlay AY. Handicap in Darier’s disease and Hailey-Hailey disease. Br J Dermatol 1996; 135: 959–963.
Barazzetti DO, Barazzetti PHO, Cavalheiro BT, Ely JB, Nunes DH, De Faria Stamm AMN. Quality of life and clinical and demographic characteristics of patients with cutaneous squamous cell carcinoma submitted to tumor resection by double-bladed scalpel. An Bras Dermatol 2019; 94: 304–312.
Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz. J Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 2007; 56: 621–623.
Rhee JS, Loberiza FR, Matthews BA, Neuburg M, Smith TL, Burzynski M. Quality of life assessment in nonmelanoma cervicofacial skin cancer. Laryngoscope 2003; 113: 215–220.
Maciel PC, Veiga-Filho J, Prado De Carvalho M, Elias F, Fonseca M, Ferreira LM, et al. Quality of life and self-esteem in patients submitted to surgical treatment of skin carcinomas: long-term results. An Bras Dermatol 2014; 89: 594–598.
Tejada VFDS, Sassi RA, Dias LZ, Medeiros SHL. Pre- and postoperative evaluation of the effect of reconstructive surgery on patient quality of life and self-esteem: a prospective study of 52 patients. Rev Bras Cir Plástica 2018; 33: 242–251.
Kiejna A, Piotrowski P, Adamowski T, Moskalewicz J, Wciórka J, Stokwiszewski J, et al. [The prevalence of common mental disorders in the population of adult Poles by sex and age structure – an EZOP Poland study] Psychiatr Pol 2015; 49: 15–27 (in Polish).
Reich A, Welz-Kubiak K, Rams L. Apprehension of the disease by patients suffering from psoriasis. Postepy Dermatol Alergol 2014; 31: 289–293.
Conrad R, Geiser F, Haidl G, Hutmacher M, Liedtke R, Wermter F. Relationship between anger and pruritus perception in patients with chronic idiopathic urticaria and psoriasis. J Eur Acad Dermatol Venereol 2008; 22: 1062–1069.
Schmitt JM, Ford DE. Role of depression in quality of life for patients with psoriasis. Dermatology 2007; 215: 17–27.
Pacan P, Szepietowski JC, Kiejna A. Stressful life events and depression in patients suffering from psoriasis vulgaris. Dermatologie und Psychosom 2003; 4: 142–145.
Roberts N, Czajkowska Z, Radiotis G, Körner A. Distress and coping strategies among patients with skin cancer. J Clin Psychol Med Settings 2013; 20: 209–214.
Fagundes CP, Glaser R, Johnson SL, Rebecca R Andridge, Eric V Yang, Michael P Di Gregorio, et al. Basal cell carcinoma: stressful life events and the tumor environment. Arch Gen Psychiatry 2012; 69: 618–626.
Visintainer MA, Volpicelli JR, Seligman MEP Tumor rejection in rats after inescapable or escapable shock. Science 1982; 216: 437–439.
Dimitrov D, Szepietowski JC. [Stigmatization in dermatology with a special focus on psoriatic patients]. Postep Hig Med Dosw 2017; 71: 1015–1022 (in Polish).
Rhee JS, Loberiza FR, Matthews BA, Neuburg M, Smith TL, Burzynski M. Quality of life assessment in nonmelanoma cervicofacial skin cancer. Laryngoscope 2003; 113: 215–220.
Published
How to Cite
License
Copyright (c) 2021 Iwona Chlebicka, Aleksandra A. Stefaniak, Łukasz Matusiak, Jacek C. Szepietowski
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
